Effect of Dipeptidyl-Peptidase 4 Inhibitors on Circulating Oxidative Stress Biomarkers in Patients with Type 2 Diabetes Mellitus

• Autores principales: Elisabetta Bigagli (Autor), Cristina Luceri (Autor), Ilaria Dicembrini (Autor), Lorenzo Tatti (Autor), Francesca Scavone (Autor), Lisa Giovannelli (Autor), Edoardo Mannucci (Autor), Maura Lodovici (Autor)
• Formato: Libro
• Publicado: MDPI AG, 2020-03-01T00:00:00Z.
• Materias: article
• Acceso en línea: Connect to this object online.

Pre-clinical studies suggested potential cardiovascular benefits of dipeptidyl peptidase-4 inhibitors (DPP4i), however, clinical trials showed neither beneficial nor detrimental effects in patients with type 2 diabetes mellitus (T2DM). We examined the effects of DPP4i on several circulating oxidativ...